323 related articles for article (PubMed ID: 36156906)
1. The Yin and Yang of the protein corona on the delivery journey of nanoparticles.
Wang YF; Zhou Y; Sun J; Wang X; Jia Y; Ge K; Yan Y; Dawson KA; Guo S; Zhang J; Liang XJ
Nano Res; 2023; 16(1):715-734. PubMed ID: 36156906
[TBL] [Abstract][Full Text] [Related]
2. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
3. Engineering a Nano/Biointerface for Cell and Organ-Selective Drug Delivery.
Song D; Xu Q
Langmuir; 2022 Aug; 38(30):9092-9098. PubMed ID: 35852946
[TBL] [Abstract][Full Text] [Related]
4. Protein corona variation in nanoparticles revisited: A dynamic grouping strategy.
Rezaei G; Daghighi SM; Haririan I; Yousefi I; Raoufi M; Rezaee F; Dinarvand R
Colloids Surf B Biointerfaces; 2019 Jul; 179():505-516. PubMed ID: 31009853
[TBL] [Abstract][Full Text] [Related]
5. Gold nanoparticle should understand protein corona for being a clinical nanomaterial.
Charbgoo F; Nejabat M; Abnous K; Soltani F; Taghdisi SM; Alibolandi M; Thomas Shier W; Steele TWJ; Ramezani M
J Control Release; 2018 Feb; 272():39-53. PubMed ID: 29305922
[TBL] [Abstract][Full Text] [Related]
6. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
Moraru C; Mincea M; Menghiu G; Ostafe V
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
[TBL] [Abstract][Full Text] [Related]
7. The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system.
Xiao W; Gao H
Int J Pharm; 2018 Dec; 552(1-2):328-339. PubMed ID: 30308270
[TBL] [Abstract][Full Text] [Related]
8. Particle Targeting in Complex Biological Media.
Dai Q; Bertleff-Zieschang N; Braunger JA; Björnmalm M; Cortez-Jugo C; Caruso F
Adv Healthc Mater; 2018 Jan; 7(1):. PubMed ID: 28809092
[TBL] [Abstract][Full Text] [Related]
9. Protein corona: challenges and opportunities for targeted delivery of nanomedicines.
Jiang Z; Chu Y; Zhan C
Expert Opin Drug Deliv; 2022 Jul; 19(7):833-846. PubMed ID: 35738018
[TBL] [Abstract][Full Text] [Related]
10. Disentangling Biomolecular Corona Interactions With Cell Receptors and Implications for Targeting of Nanomedicines.
Aliyandi A; Zuhorn IS; Salvati A
Front Bioeng Biotechnol; 2020; 8():599454. PubMed ID: 33363128
[TBL] [Abstract][Full Text] [Related]
11. The protein corona and its effects on nanoparticle-based drug delivery systems.
Li H; Wang Y; Tang Q; Yin D; Tang C; He E; Zou L; Peng Q
Acta Biomater; 2021 Jul; 129():57-72. PubMed ID: 34048973
[TBL] [Abstract][Full Text] [Related]
12. Engineering at the nano-bio interface: harnessing the protein corona towards nanoparticle design and function.
Pinals RL; Chio L; Ledesma F; Landry MP
Analyst; 2020 Aug; 145(15):5090-5112. PubMed ID: 32608460
[TBL] [Abstract][Full Text] [Related]
13. A Review for Uncovering the "Protein-Nanoparticle Alliance": Implications of the Protein Corona for Biomedical Applications.
Önal Acet B; Gül D; Stauber RH; Odabaşı M; Acet Ö
Nanomaterials (Basel); 2024 May; 14(10):. PubMed ID: 38786780
[TBL] [Abstract][Full Text] [Related]
14.
Singh N; Marets C; Boudon J; Millot N; Saviot L; Maurizi L
Nanoscale Adv; 2021 Mar; 3(5):1209-1229. PubMed ID: 36132858
[TBL] [Abstract][Full Text] [Related]
15. Protein Corona-Enabled Systemic Delivery and Targeting of Nanoparticles.
Chen D; Ganesh S; Wang W; Amiji M
AAPS J; 2020 Jun; 22(4):83. PubMed ID: 32495039
[TBL] [Abstract][Full Text] [Related]
16. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
[TBL] [Abstract][Full Text] [Related]
17. Influence of surface chemistry and morphology of nanoparticles on protein corona formation.
Bilardo R; Traldi F; Vdovchenko A; Resmini M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1788. PubMed ID: 35257495
[TBL] [Abstract][Full Text] [Related]
18. Transportation of AIE-visualized nanoliposomes is dominated by the protein corona.
Wang YF; Zhang C; Yang K; Wang Y; Shan S; Yan Y; Dawson KA; Wang C; Liang XJ
Natl Sci Rev; 2021 Jun; 8(6):nwab068. PubMed ID: 34691676
[TBL] [Abstract][Full Text] [Related]
19. Protein corona: Friend or foe? Co-opting serum proteins for nanoparticle delivery.
Kim W; Ly NK; He Y; Li Y; Yuan Z; Yeo Y
Adv Drug Deliv Rev; 2023 Jan; 192():114635. PubMed ID: 36503885
[TBL] [Abstract][Full Text] [Related]
20. The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery.
Corbo C; Molinaro R; Parodi A; Toledano Furman NE; Salvatore F; Tasciotti E
Nanomedicine (Lond); 2016 Jan; 11(1):81-100. PubMed ID: 26653875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
